RELATIONSHIP BETWEEN INHIBITION OF CYCLIC-AMP PRODUCTION IN CHINESE-HAMSTER OVARY CELLS EXPRESSING THE RAT D-2(444) RECEPTOR AND ANTAGONIST AGONIST BINDING RATIOS

被引:12
作者
HARLEY, EA [1 ]
MIDDLEMISS, DN [1 ]
RAGAN, CI [1 ]
机构
[1] MERCK SHARP & DOHME LTD,RES LABS,HARLOW CM20 2QR,ESSEX,ENGLAND
关键词
RAT D-2(444) RECEPTOR; H-3] (-)-SULPIRIDE; H-3] (-)-N-0437; CYCLIC AMP PRODUCTION; CHO CELL;
D O I
10.1111/j.1476-5381.1995.tb15041.x
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
1 Radioligand binding assays using [H-3]-(-)-sulpiride, in the presence of 1 mM ethylenediaminetetraacetic acid (EDTA) and 100 mu M guanylylimidodiphosphate (GppNHp) and [H-3]-N0437 were developed to label the low and high agonist affinity states of the rD(2(444)) receptor (long form of the rat D-2 receptor) respectively. The ratios of the affinities of compounds in these two assays (K-app [H-3]-(-)-supiride/K-app [H-3]-N-0437) were then calculated. 2 The prediction that the binding ratio reflected the functional efficacy of a compound was supported by measurement of the ability of a number of compounds acting at dopamine receptors to inhibit rD(2(444))-mediated inhibition of cyclic AMP production. When the rank order of the ratios of a number of these compounds was compared to their ability to inhibit the production of cyclic AMP, a significant correlation was seen (Spearman rank correlation coefficient=0.943, P=0.01). 3 In conclusion, the sulpiride/N-0437 binding ratio reliably predicted the efficacy of compounds acting at dopamine receptors to inhibit cyclic AMP production mediated by the rD(2(444)) receptor.
引用
收藏
页码:1307 / 1313
页数:7
相关论文
共 35 条
[1]  
ALBERT PR, 1990, J BIOL CHEM, V265, P2098
[2]  
BARTON AC, 1991, MOL PHARMACOL, V39, P650
[3]  
BATES MD, 1991, MOL PHARMACOL, V39, P55
[4]   CHARACTER OF THE MUSCARINIC RECEPTORS IN DIFFERENT REGIONS OF THE RAT-BRAIN [J].
BIRDSALL, NJM ;
HULME, EC ;
BURGEN, A .
PROCEEDINGS OF THE ROYAL SOCIETY SERIES B-BIOLOGICAL SCIENCES, 1980, 207 (1166) :1-12
[5]  
BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
[6]   CLONING AND EXPRESSION OF A RAT D2 DOPAMINE RECEPTOR CDNA [J].
BUNZOW, JR ;
VANTOL, HHM ;
GRANDY, DK ;
ALBERT, P ;
SALON, J ;
CHRISTIE, MJ ;
MACHIDA, CA ;
NEVE, KA ;
CIVELLI, O .
NATURE, 1988, 336 (6201) :783-787
[7]   DIFFERENCES IN THE LIGAND-BINDING PROPERTIES OF THE SHORT AND LONG VERSIONS OF THE D2 DOPAMINE RECEPTOR [J].
CASTRO, SW ;
STRANGE, PG .
JOURNAL OF NEUROCHEMISTRY, 1993, 60 (01) :372-375
[8]  
CHENG Y, 1973, BIOCHEM PHARMACOL, V22, P3099
[9]   MOLECULAR DIVERSITY OF THE DOPAMINE-RECEPTORS [J].
CIVELLI, O ;
BUNZOW, JR ;
GRANDY, DK .
ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, 1993, 33 :281-307
[10]   MOLECULAR-BIOLOGY OF THE DOPAMINE-RECEPTORS [J].
CIVELLI, O ;
BUNZOW, JR ;
GRANDY, DK ;
ZHOU, QY ;
VANTOL, HHM .
EUROPEAN JOURNAL OF PHARMACOLOGY-MOLECULAR PHARMACOLOGY SECTION, 1991, 207 (04) :277-286